BURINEX

This brand name is authorized in Austria, Canada, France, Ireland, Malta, Netherlands, New Zealand, Singapore, South Africa

Active ingredients

The drug BURINEX contains one active pharmaceutical ingredient (API):

1 Bumetanide UNII 0Y2S3XUQ5H - BUMETANIDE

Bumetanide is a potent loop diuretic with a rapid onset and a short duration of action. The primary site of action is the ascending limb of the loop of Henle where it exerts inhibiting effects on electrolyte reabsorption, causing its diuretic and natriuretic action. Read about Bumetanide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BURINEX Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C03CA02	Bumetanide	C Cardiovascular system → C03 Diuretics → C03C High-ceiling diuretics → C03CA Sulfonamides, plain
Discover more medicines within C03CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00728276, 00728284
Country: FR	Base de données publique des médicaments	Identifier(s): 61834055, 67563415, 68232635
Country: IE	Health Products Regulatory Authority	Identifier(s): 31596
Country: MT	Medicines Authority	Identifier(s): MA1303/00101, MA1303/00102, MA1303/00103, PI1438/04601A, PI908/13901A
Country: NL	Z-Index G-Standaard	Identifier(s): 13277731
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 26360
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1816
Country: SG	Health Sciences Authority	Identifier(s): 00718P, 01421P
Country: ZA	Health Products Regulatory Authority	Identifier(s): G/18.1/94, J/18.1/36